The basis of the Academic CRO activity is the preparation of documentation for clinical researches and their conduct.
Range of activities:In 2020, the Department of Non-Commercial Clinical Research Team is implementing three non-commercial clinical trials projects as CRO:
1. Dual Antithrombotic Therapy with Dabigatran and Ticagrelor in Patients with Acute Coronary Syndrome and Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention (ADONIS-PCI), leader Prof. Miłosz Jaguszewski, M.D., Ph.D.
2. Evaluation of the effectiveness of the use of metoprolol in the prevention of cardiomyopathy and cardiac deaths in patients with Duchenne muscular dystrophy, leader Joanna Kwiatkowska, M.D., Ph.D., D Sc.
3. Phase III clinical research evaluating the efficacy and safety of Avigan (favipiravir) compared to standard care in accordance with the current AOTMiT recommendations in patients with SARS-C0V-2 infection, *leader Tomasz Smiatacz, M.D., Ph.D., D.Sc.
Persons responsible: